These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 19514119)

  • 1. Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer.
    Loddenkemper C; Hoffmann C; Stanke J; Nagorsen D; Baron U; Olek S; Huehn J; Ritz JP; Stein H; Kaufmann AM; Schneider A; Cichon G
    Cancer Sci; 2009 Jun; 100(6):1112-7. PubMed ID: 19514119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory T cells in a spectrum of HPV-induced cervical lesions: cervicitis, cervical intraepithelial neoplasia and squamous cell carcinoma.
    Adurthi S; Krishna S; Mukherjee G; Bafna UD; Devi U; Jayshree RS
    Am J Reprod Immunol; 2008 Jul; 60(1):55-65. PubMed ID: 18593438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of FoxP3-positive regulatory T-cells in regressive and progressive cervical dysplasia.
    Vattai A; Kremer N; Meister S; Beyer S; Keilmann L; Hester A; Temelkov M; Heidegger H; Schmoeckel E; Kessler M; Mahner S; Jeschke U; Hertlein L; Kolben T
    J Cancer Res Clin Oncol; 2022 Feb; 148(2):377-386. PubMed ID: 34739585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of cervical regulatory T cells in HPV-related cervical intraepithelial neoplasia (CIN) correlates inversely with spontaneous regression of CIN.
    Kojima S; Kawana K; Tomio K; Yamashita A; Taguchi A; Miura S; Adachi K; Nagamatsu T; Nagasaka K; Matsumoto Y; Arimoto T; Oda K; Wada-Hiraike O; Yano T; Taketani Y; Fujii T; Schust DJ; Kozuma S
    Am J Reprod Immunol; 2013 Feb; 69(2):134-41. PubMed ID: 23057776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation.
    Cohen AD; Schaer DA; Liu C; Li Y; Hirschhorn-Cymmerman D; Kim SC; Diab A; Rizzuto G; Duan F; Perales MA; Merghoub T; Houghton AN; Wolchok JD
    PLoS One; 2010 May; 5(5):e10436. PubMed ID: 20454651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of Tregs by anti-glucocorticoid induced TNF receptor antibody enhances the antitumor immunity of interferon-α gene therapy for pancreatic cancer.
    Aida K; Miyakawa R; Suzuki K; Narumi K; Udagawa T; Yamamoto Y; Chikaraishi T; Yoshida T; Aoki K
    Cancer Sci; 2014 Feb; 105(2):159-67. PubMed ID: 24289533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of indoleamine 2, 3-dioxygenase and the recruitment of Foxp3-expressing regulatory T cells in the development and progression of uterine cervical cancer.
    Nakamura T; Shima T; Saeki A; Hidaka T; Nakashima A; Takikawa O; Saito S
    Cancer Sci; 2007 Jun; 98(6):874-81. PubMed ID: 17433037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local lymphocytes and nitric oxide synthase in the uterine cervical stroma of patients with grade III cervical intraepithelial neoplasia.
    Silva CS; Michelin MA; Etchebehere RM; Adad SJ; Murta EF
    Clinics (Sao Paulo); 2010 Jun; 65(6):575-81. PubMed ID: 20613932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequencies and role of regulatory T cells in patients with (pre)malignant cervical neoplasia.
    Visser J; Nijman HW; Hoogenboom BN; Jager P; van Baarle D; Schuuring E; Abdulahad W; Miedema F; van der Zee AG; Daemen T
    Clin Exp Immunol; 2007 Nov; 150(2):199-209. PubMed ID: 17937675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory T cell depletion enhances tumor specific CD8 T-cell responses, elicited by tumor antigen NY-ESO-1b in hepatocellular carcinoma patients, in vitro.
    Zhang HH; Mei MH; Fei R; Liao WJ; Wang XY; Qin LL; Wang JH; Wei L; Chen HS
    Int J Oncol; 2010 Apr; 36(4):841-8. PubMed ID: 20198327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.
    Wang X; Wang T; Xu M; Xiao L; Luo Y; Huang W; Zhang Y; Geng W
    Hum Immunol; 2014 Dec; 75(12):1203-9. PubMed ID: 25446402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tbet-positive regulatory T cells accumulate in oropharyngeal cancers with ongoing tumor-specific type 1 T cell responses.
    Santegoets SJ; Duurland CL; Jordanova ES; van Ham JJ; Ehsan I; van Egmond SL; Welters MJP; van der Burg SH
    J Immunother Cancer; 2019 Jan; 7(1):14. PubMed ID: 30658697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nocardia Rubra Cell Wall Skeleton Up-Regulates T Cell Subsets and Inhibits PD-1/PD-L1 Pathway to Promote Local Immune Status of Patients With High-Risk Human Papillomavirus Infection and Cervical Intraepithelial Neoplasia.
    Chen W; Zhang Y; Zhao C; Shao S; Zhang Y; Li X; Bai X; Guo Q; Liu Q; Tang J; Zhang L
    Front Immunol; 2020; 11():612547. PubMed ID: 33552075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV16 tumor associated macrophages suppress antitumor T cell responses.
    Lepique AP; Daghastanli KR; Cuccovia IM; Villa LL
    Clin Cancer Res; 2009 Jul; 15(13):4391-400. PubMed ID: 19549768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4(+)FOXP3(+) regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix.
    Shah W; Yan X; Jing L; Zhou Y; Chen H; Wang Y
    Cell Mol Immunol; 2011 Jan; 8(1):59-66. PubMed ID: 21200385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of CD4+CD25(high) FOXP3+ Tregs in lymphomas and tumors are complex.
    Ke X; Wang J; Li L; Chen IH; Wang H; Yang XF
    Front Biosci; 2008 May; 13():3986-4001. PubMed ID: 18508492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ratios of CD8+ T cells to CD4+CD25+ FOXP3+ and FOXP3- T cells correlate with poor clinical outcome in human serous ovarian cancer.
    Preston CC; Maurer MJ; Oberg AL; Visscher DW; Kalli KR; Hartmann LC; Goode EL; Knutson KL
    PLoS One; 2013; 8(11):e80063. PubMed ID: 24244610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of invariant NKT cells with increased IFN-γ production in persistent high-risk HPV-infected high-grade cervical intraepithelial neoplasia.
    Hu T; Yang P; Zhu H; Chen X; Xie X; Yang M; Liu S; Wang H
    Diagn Pathol; 2015 Apr; 10():20. PubMed ID: 25885042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of gut-derived intraepithelial lymphocyte (IEL) residing in human papillomavirus (HPV)-infected intraepithelial neoplastic lesions.
    Kojima S; Kawana K; Fujii T; Yokoyama T; Miura S; Tomio K; Tomio A; Yamashita A; Adachi K; Sato H; Nagamatsu T; Schust DJ; Kozuma S; Taketani Y
    Am J Reprod Immunol; 2011 Nov; 66(5):435-43. PubMed ID: 21749545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterising the local immune responses in cervical intraepithelial neoplasia: a cross-sectional and longitudinal analysis.
    Woo YL; Sterling J; Damay I; Coleman N; Crawford R; van der Burg SH; Stanley M
    BJOG; 2008 Dec; 115(13):1616-21; discussion 1621-2. PubMed ID: 19035938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.